Skip to content

FLAB AD HOC

Active
Private limited companyfounded 2024active for 2 yearsRue Jules Antheunis 51, 7030 Mons, BelgiumKBO/BCE: BE 1010.262.324
Summary

FLAB AD HOC has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €39,349 and a net result of €36,349. Its solvency ranks better than 25% of 2,164 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€121,765total assets 2024
Equity
€39,349
Profit
€36,349
Turnover not published (abbreviated format)
Financial health
55 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.8%
Structure
Accounts filed 92 days late0 of 1 deed read
Why 55raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 31-10-2025)1 financial year not filed after the legal deadline; latest accounts 92 days late; 1 of the last 3 lateFounded in 2024lowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2024
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 48% of its sector peers (NACE 86, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 57
equity 32.3% of total assets
Liquidity 60
short-term debt 43.5% · cash 24.7%
Profitability 100
return on assets 29.9%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,011 companies, NACE 86, micro)
Last 24 months 07-2025: 0.3% 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.1%▼ -0.2 percentage points vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.2%▲ +0.1 percentage points vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026 09-2026: 0.4%▲ +0.1 percentage points vs 08-2026 10-2026: 0.8%▲ +0.4 percentage points vs 09-2026highest value
Credit of up to €2,000 on 30-day terms, only on tighter conditions
Liquidity insufficient (current ratio 0.95; short-term debt: 43.5% and cash: 24.7% of total assets), and 67.7% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 28% on solvency, 37% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2024 (filed 31-10-2025)
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 92 days late; 1 of the last 3 late
NBB · filings
raises risk · Founded in 2024
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 2164 sector peers (2024).
NBB · sector comparison
Position among 2164 sector peers
Solvency
better than 25%
← weakest strongest →
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-10-2025, 92 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers.
NBB · 1 filing
Deviation from the deadline
2024
92 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its 2024 accounts 92 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · abbreviated…
  2. Founder · Director in officeIncorporation · Founding capital

Key points

  • Caution: Among the weakest 14% on equitysector median €511,696 · 2,164 companies €39,349 View
  • Caution: Latest accounts filed lateafter the legal deadline 92 days View
  • Total assets 2024first financial year filed €121,765 View

By topic

Financials

Financial year
2024
Total assets
€121,765
Profit
€36,349
Solvency
32.3%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
11-06-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.